BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24840952)

  • 1. Interaction of ribosomal protein L22 with casein kinase 2α: a novel mechanism for understanding the biology of non-small cell lung cancer.
    Yang M; Sun H; He J; Wang H; Yu X; Ma L; Zhu C
    Oncol Rep; 2014 Jul; 32(1):139-44. PubMed ID: 24840952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of ribosomal protein L22 in non-small cell lung cancer.
    Yang M; Sun H; Wang H; Zhang S; Yu X; Zhang L
    Med Oncol; 2013; 30(3):646. PubMed ID: 23797773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK2 phosphorylates AP-2α and increases its transcriptional activity.
    Ren K; Xian S; He F; Zhang W; Ding X; Wu Y; Yang L; Zhou J; Gao X; Zhang J
    BMB Rep; 2011 Jul; 44(7):490-5. PubMed ID: 21777522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of casein kinase II with ribosomal protein L22 of Drosophila melanogaster.
    Zhao W; Bidwai AP; Glover CV
    Biochem Biophys Res Commun; 2002 Oct; 298(1):60-6. PubMed ID: 12379220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in non-small cell lung cancer cells.
    Yang HJ; Youn H; Seong KM; Jin YW; Kim J; Youn B
    J Biol Chem; 2013 Feb; 288(5):2965-75. PubMed ID: 23188828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening ubiquitin/ribosomal protein S27a by yeast two-hybridization system].
    Huang GH; Liang JY; Chen B; Liu XG; Liang NC
    Ai Zheng; 2005 Jan; 24(1):40-6. PubMed ID: 15642198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome.
    Perera Y; Ramos Y; Padrón G; Caballero E; Guirola O; Caligiuri LG; Lorenzo N; Gottardo F; Farina HG; Filhol O; Cochet C; Perea SE
    Mol Cell Biochem; 2020 Jul; 470(1-2):63-75. PubMed ID: 32405972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells.
    Sun K; Xue H; Wang H; Wang Q; Zuo XR; Xie WP; Wang H
    Int J Mol Med; 2012 Aug; 30(2):351-7. PubMed ID: 22580622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
    Lan H; Lin CY; Yuan HY; Xiong B
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):742-6. PubMed ID: 22335905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
    Del Toro N; Fernandez-Ruiz A; Mignacca L; Kalegari P; Rowell MC; Igelmann S; Saint-Germain E; Benfdil M; Lopes-Paciencia S; Brakier-Gingras L; Bourdeau V; Ferbeyre G; Lessard F
    Cell Cycle; 2019; 18(6-7):759-770. PubMed ID: 30874462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint.
    Anderson SJ; Lauritsen JP; Hartman MG; Foushee AM; Lefebvre JM; Shinton SA; Gerhardt B; Hardy RR; Oravecz T; Wiest DL
    Immunity; 2007 Jun; 26(6):759-72. PubMed ID: 17555992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
    Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.
    Bae KM; Wang H; Jiang G; Chen MG; Lu L; Xiao L
    Cancer Res; 2007 Jul; 67(13):6053-63. PubMed ID: 17616661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
    Ahmad KA; Wang G; Ahmed K
    Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D.
    Ling B; Zheng H; Fu G; Yuan J; Shi T; Chen S; Liu Y; Liu Y; Cao Y; Zheng S; Guo S; Han N; Gao Y; Cheng S; Zhang K
    Lung Cancer; 2013 Feb; 79(2):104-10. PubMed ID: 23182661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.
    Zhang P; Wang J; Gao W; Yuan BZ; Rogers J; Reed E
    Mol Cancer; 2004 May; 3():14. PubMed ID: 15125777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression, purification, molecular characterization and the effect on tumor growth of ribosomal protein L22 from the Giant Panda (Ailuropoda melanoleuca).
    Li J; Hou Y; Ding X; Hou W; Song B; Zeng Y
    Mol Biol Rep; 2014 May; 41(5):3529-39. PubMed ID: 24504451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a cleavage stimulation factor, 3' pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer.
    Aragaki M; Takahashi K; Akiyama H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Sep; 17(18):5889-900. PubMed ID: 21813631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.